Preview Mode Links will not work in preview mode

Sep 11, 2020

Featuring an interview with Dr Petros Grivas about recent advances in the use of immunotherapy for urothelial bladder cancer, including the following topics:

  • Immunotherapy for Urothelial Bladder Carcinoma — Dr Grivas (00:00)
  • Choice of first-line maintenance therapy for patients with metastatic UBC; clinical experience with avelumab (1:07:55)
  • Duration of pembrolizumab therapy for patients with non-muscle invasive bladder cancer (1:11:32)

CME information and select publications